• Dr. Xu Awarded RO1

    May 15, 2018

    The Dr. Chunhui Xu's RO1 award aims to examine stem cell-derived cardiomyocytes in response to a multipronged approach for promotion of cardiomyocyte maturation. Findings from this study will help to address key issues facing applications of cardiomyocytes derived from human pluripotent stem cells in cardiotoxicity testing, disease modeling, developmental biology and regenerative medicine.

  • The Next Frontier in Biomedical Engineering

    May 15, 2018

    Michael Davis changes the landscape of pediatric cardiology with stem cell therapies and 3D printing.

  • Dr. Mahle Leads Emory Site Pediatric Heart Network (PHN)

    April 02, 2018

    The mission of the Pediatric Heart Network (PHN) is to improve the health of children and adults with structural congenital heart defects, as well as children with acquired heart disease through multi-center clinical research. The Emory University Clinical Research Center combines the strengths and experience of Children's Healthcare of Atlanta, the Sibley Heart Center, the Emory Adult Congenital Heart Center, and Emory University School of Medicine with the goal of participating in a cooperative and interactive manner with the other Clinical Research Centers, the NHLBI, and the DCC to carry out the mission of the PHN.

  • New Faculty Welcome - Vahid Serpooshan, PhD

    March 27, 2018

    Vahid Serpooshan received his undergraduate degrees (BSc and MSc) in Materials Science and Engineering at Sharif University in Iran. He then received his PhD in biomaterials for tissue engineering from McGill University. His PhD thesis focused on design and optimization…

  • Dr. Xu,“Human Pluripotent Stem Cells, Cardiac Disease Modeling, and the Impact of Microgravity”

    February 14, 2018

    Dr. Chunhui Xu presented "Human Pluripotent Stem Cells, Cardiac Disease Modeling, and the Impact of Microgravity" at the February 9th Pediatric Research Grand Rounds.    To view Dr. Xu's presentation, click here.…

  • “Long-Term Transplant-Free Survival After Repair of Total Anomalous Pulmonary Venous Connection”

    January 31, 2018

    Read full article here. Background Long-term survival, risk of transplantation, and causes of death after repair of total anomalous pulmonary venous connection (TAPVC) remain unknown. By linking the Pediatric Cardiac Care Consortium with the National Death Index and the United…

  • Dr. Davis Awarded R01 “Peg Hydrogels for Progenitor Cell Delivery”

    January 30, 2018

    Cardiovascular disease is a leading cause of morbidity and mortality worldwide and effective diagnostic and treatment options are greatly needed. Cell therapy trials show promise, but still require new strategies to improve efficacy. We propose that delivery of cells within a modular, biodegradable hydrogel with cardiac ligands will improve transplanted cell therapy efficacy leading to improved function.

  • Dr. Hyacinith Awarded RO1 “Mechanism of Cerebral Vaculopahty and Stroke in Sickle Cell Disease”

    January 30, 2018

    A 2015 HeRO pilot awardee, Dr. Hyacinith's initial proposal "In vivo imaging and identification of cerebral vasculopathy in murine sickle cell disease" lead to data supporting his most recent RO1 award.